1271 related articles for article (PubMed ID: 17678964)
21. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
Jellinger K
J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
[TBL] [Abstract][Full Text] [Related]
22. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
23. Neuroinflammatory processes in Parkinson's disease.
Hirsch EC; Hunot S; Hartmann A
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S9-S15. PubMed ID: 15885630
[TBL] [Abstract][Full Text] [Related]
24. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats.
Cicchetti F; Lapointe N; Roberge-Tremblay A; Saint-Pierre M; Jimenez L; Ficke BW; Gross RE
Neurobiol Dis; 2005 Nov; 20(2):360-71. PubMed ID: 16242641
[TBL] [Abstract][Full Text] [Related]
25. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
Tsai SJ
Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
[TBL] [Abstract][Full Text] [Related]
26. Microglial activation is not prevented by tacrolimus but dopamine neuron damage is reduced in a rat model of Parkinson's disease progression.
Wright AK; Miller C; Williams M; Arbuthnott G
Brain Res; 2008 Jun; 1216():78-86. PubMed ID: 18495090
[TBL] [Abstract][Full Text] [Related]
27. Microglia and Alzheimer's disease pathogenesis.
Streit WJ
J Neurosci Res; 2004 Jul; 77(1):1-8. PubMed ID: 15197750
[TBL] [Abstract][Full Text] [Related]
28. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system.
Hunter RL; Dragicevic N; Seifert K; Choi DY; Liu M; Kim HC; Cass WA; Sullivan PG; Bing G
J Neurochem; 2007 Mar; 100(5):1375-86. PubMed ID: 17254027
[TBL] [Abstract][Full Text] [Related]
29. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
[TBL] [Abstract][Full Text] [Related]
30. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
[TBL] [Abstract][Full Text] [Related]
31. Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
Mena MA; García de Yébenes J
Neuroscientist; 2008 Dec; 14(6):544-60. PubMed ID: 19029058
[TBL] [Abstract][Full Text] [Related]
32. The microglial phagocytic role with specific plaque types in the Alzheimer disease brain.
D'Andrea MR; Cole GM; Ard MD
Neurobiol Aging; 2004; 25(5):675-83. PubMed ID: 15172747
[TBL] [Abstract][Full Text] [Related]
33. Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference.
Rao KS; Hegde ML; Anitha S; Musicco M; Zucca FA; Turro NJ; Zecca L
Prog Neurobiol; 2006 Apr; 78(6):364-73. PubMed ID: 16682109
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
Lee JK; Jin HK; Bae JS
Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
[TBL] [Abstract][Full Text] [Related]
35. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and neurodegeneration in Parkinson's disease.
McGeer PL; McGeer EG
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S3-7. PubMed ID: 15109580
[TBL] [Abstract][Full Text] [Related]
37. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
Koistinaho M; Koistinaho J
Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
[TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP.
Kim S; Cho SH; Kim KY; Shin KY; Kim HS; Park CH; Chang KA; Lee SH; Cho D; Suh YH
J Neurochem; 2009 Jun; 109(5):1483-96. PubMed ID: 19457162
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint.
Marx F; Blasko I; Grubeck-Loebenstein B
Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867
[TBL] [Abstract][Full Text] [Related]
40. Assessing the contribution of inflammation in models of Alzheimer's disease.
Johnston H; Boutin H; Allan SM
Biochem Soc Trans; 2011 Aug; 39(4):886-90. PubMed ID: 21787318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
